FRANKLIN LAKES, N.J.—BD Life Sciences, a segment of leading global medical technology company BD (Becton, Dickinson and Company), recently completed its acquisition of Cellular Research Inc., which brings with it advanced tools for massively parallel single-cell genetic analysis based on its proprietary Molecular Indexing technology. The companies have been collaborating since September 2014 to develop single-cell analysis workflows for Cellular Research’s Precise product line and BD’s FACS instruments and software, and presented a study at the Advances in Genome Biology and Technology Meeting demonstrating that the combined workflow can enhance the detection and quantification of expression in single and/or multiple cell samples.

 

Linda Tharby, executive vice president and president of BD Life Sciences, said that “The addition of Cellular Research builds on our GenCell acquisition and underscores BD’s commitment to a genomics strategy focused on next- generation sequencing sample preparation.”